The global stroke management market is anticipated to witness substantial growth through 2032, owing to the rising count of cardiovascular disease cases worldwide. In addition, shifting patient preference towards minimally invasive procedures is also expected to shape industry outlook. Such surgical procedures, such as endovascular thrombectomy, have seen a marked rise across healthcare facilities as they yield satisfactory clinical results.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3550
Technological advancements in the field of medical devices is expected to bolster industry revenues as well. Minimally invasive procedures such as stereotactic surgery, use advanced imaging-based surgical localization with a 3-D roadmap systems, which help identify the clot and the suitable method for its removal.
In their efforts to further enhance patient outcomes, many industry players have started to marry technology with innovative surgical procedures. For instance, Cerebrotech Medical Systems, a neurotechnology device firm, introduced a product called Cerebrotech Visor, a VIPS technology-based device for neurological evaluation.
The device also received a CE mark in Europe for measuring stroke-related bioimpedance asymmetry. The company is further researching the device's feasibility in certain brain pathologies including stroke.
The overall stroke management market landscape is classified into segments such as type, product, end-use, and regional landscape.
Based on type, the market is categorized into hemorrhagic, ischemic, transient ischemic attack (TIA), and others. The ischemic segment held the largest market share of over USD 30 billion in 2022, fueled by the rising cases of ischemic disease, especially among women.
In fact, as per the World Stroke Organization (WSO), women account for over half (51%) of all active cases of ischemic stroke globally. A 2020 study estimates that ischemic heart disease affects approximately 126 million people worldwide, which is 1.72% of the global population.
On the basis of product, the industry is bifurcated into diagnostic devices and therapeutic devices. The diagnostic devices segment is expected to witness substantial growth from 2023-2032, owing to increasing public health programs that encourage the population to undergo periodic screening examinations for the early detection of specific chronic diseases including cancer, cardiovascular diseases, and others.
Based on end-use, the industry is divided into ambulatory surgical centers, diagnostic centers, hospitals, and others. Amongst them, the diagnostic centers segment held a multi-billion revenue share in 2022, primarily owing to the rising occurrences of neurological and cardiovascular ailments across the globe.
As per CDC, every 34 seconds a person dies due to cardiovascular disease in the U.S. Many world governments are focusing on improving their diagnosis capabilities to prevent CVDs-related deaths.
Regionally, the industry is classified into Europe, Asia Pacific, North America, MEA, and LATAM. The North America stroke management industry accounted for a lion's share of the overall market landscape in 2022, on account of the region's robust healthcare sector.
Moreover, the sector is also witnessing a growing number of investments in recent years, which further shapes the regional outlook. Increasing per capita income of North America's female population and rising urbanization are expected to deliver an additional capacity for growth to the market.
Request for customization @ https://www.gminsights.com/roc/3550
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.6 Secondary
1.6.1 Paid sources
1.6.2 Unpaid sources
1.7 Primary
Chapter 2 Executive Summary
2.1 Stroke management industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Product trends
2.1.4 End-use trends
2.1.5 Regional trends
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/stroke-management-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
According to IMARC Group’s latest report, titled “Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global stroke management market exhibited moderate growth during 2015-2020.
It relies on an echocardiogram, cerebral angiogram, carotid ultrasound, blood tests, magnetic resonance imaging (MRI), and computerized tomography (CT) scan and blood tests for a complete evaluation.
As per the assessment and patient’s condition, it assists physicians in opting for treatment options like endovascular procedures, intubation, intravenous (IV) medication, and surgeries.Request for a PDF sample of this report: https://www.imarcgroup.com/stroke-management-market/requestsamplePresently, there is a growing prevalence of chronic diseases, such as migraine, hypertension, diabetes, obesity, and cardiac diseases around the world.
Besides this, a significant rise in the geriatric population, which is relatively more vulnerable to stroke, is escalating catalyzing the demand for efficient stroke management worldwide.
This, along with increasing awareness about the benefits of early diagnosis and treatment, is driving the market.
Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.Competitive Landscape with Key Players:Abbott LaboratoriesBraun Melsungen AGBoston Scientific CorporationBristol-Myers Squibb CompanyCardinal HealthGeneral Electric CompanyGlaxoSmithKline plcMedtronic plcMerck & Co. Inc.Siemens Healthineers AG (Siemens AG).Market Segmentation:Breakup by Type:DiagnosticsComputed Tomography Scan (CT Scan)Magnetic Resonance Imaging (MRI)Carotid UltrasoundCerebral AngiographyElectrocardiographyEchocardiographyOthersTherapeuticsTissue Plasminogen ActivatorAnticoagulantAntiplateletAntihypertensiveBreakup by Application:Ischemic StrokeHaemorrhagic StrokeOthersBreakup by End User:HospitalsAmbulatory Surgical CentersDiagnostic CentersOthersBreakup by Region:North America (United States, Canada)Europe (Germany, France, United Kingdom, Italy, Spain, Others)Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)Latin America (Brazil, Mexico, Others)Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/stroke-management-marketWe are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc.
